{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:34:25Z","timestamp":1791246865385,"version":"4.1.0"},"reference-count":60,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2006,11,1]],"date-time":"2006-11-01T00:00:00Z","timestamp":1162339200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurobiology of Aging"],"published-print":{"date-parts":[[2006,11]]},"DOI":"10.1016\/j.neurobiolaging.2005.09.039","type":"journal-article","created":{"date-parts":[[2005,11,8]],"date-time":"2005-11-08T12:12:12Z","timestamp":1131451932000},"page":"1618-1631","source":"Crossref","is-referenced-by-count":110,"title":["Blockade of the insulin-like growth factor I receptor in the choroid plexus originates Alzheimer's-like neuropathology in rodents: New cues into the human disease?"],"prefix":"10.1016","volume":"27","author":[{"given":"Eva","family":"Carro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Luis","family":"Trejo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Spuch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delphine","family":"Bohl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Michel","family":"Heard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio","family":"Torres-Aleman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.neurobiolaging.2005.09.039_bib1","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1210\/jc.84.2.471","article-title":"Insulin-like growth factor-I and cognitive function in healthy older men","volume":"84","author":"Aleman","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.neurobiolaging.2005.09.039_bib2","doi-asserted-by":"crossref","first-page":"29","DOI":"10.2165\/00002512-200016010-00003","article-title":"Insulin-like growth factor I: implications in aging","volume":"16","author":"Arvat","year":"2000","journal-title":"Drugs Aging"},{"issue":"2","key":"10.1016\/j.neurobiolaging.2005.09.039_bib3","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1152\/physrev.00024.2003","article-title":"Role of tau protein in both physiological and pathological conditions","volume":"84","author":"Avila","year":"2004","journal-title":"Physiol Rev"},{"issue":"2","key":"10.1016\/j.neurobiolaging.2005.09.039_bib4","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S0306-4522(03)00474-3","article-title":"Efflux of human and mouse amyloid beta proteins 1\u201340 and 1\u201342 from brain: impairment in a mouse model of Alzheimer's disease","volume":"121","author":"Banks","year":"2003","journal-title":"Neuroscience"},{"key":"10.1016\/j.neurobiolaging.2005.09.039_bib5","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1749-6632.1993.tb26203.x","article-title":"Patterns of insulin-like growth factor and IGF receptor gene expression in the brain. Functional implications","volume":"692","author":"Bondy","year":"1993","journal-title":"Ann N Y Acad Sci"},{"issue":"12","key":"10.1016\/j.neurobiolaging.2005.09.039_bib6","doi-asserted-by":"crossref","first-page":"6826","DOI":"10.1073\/pnas.97.12.6826","article-title":"Alzheimer-like neurodegeneration in aged antinerve growth factor transgenic mice","volume":"97","author":"Capsoni","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"issue":"8","key":"10.1016\/j.neurobiolaging.2005.09.039_bib7","doi-asserted-by":"crossref","first-page":"2926","DOI":"10.1523\/JNEUROSCI.20-08-02926.2000","article-title":"Circulating insulin-like growth factor I mediates effects of exercise on the brain","volume":"20","author":"Carro","year":"2000","journal-title":"J Neurosci"},{"issue":"1\u20133","key":"10.1016\/j.neurobiolaging.2005.09.039_bib8","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ejphar.2004.02.050","article-title":"The role of insulin and insulin-like growth factor I in the molecular and cellular mechanisms underlying the pathology of Alzheimer's disease","volume":"490","author":"Carro","year":"2004","journal-title":"Eur J Pharmacol"},{"issue":"15","key":"10.1016\/j.neurobiolaging.2005.09.039_bib9","doi-asserted-by":"crossref","first-page":"5678","DOI":"10.1523\/JNEUROSCI.21-15-05678.2001","article-title":"Circulating insulin-like growth factor I mediates the protective effects of physical exercise against brain insults of different etiology and anatomy","volume":"21","author":"Carro","year":"2001","journal-title":"J Neurosci"},{"issue":"12","key":"10.1016\/j.neurobiolaging.2005.09.039_bib10","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1038\/nm793","article-title":"Serum insulin-like growth factor I regulates brain amyloid-beta levels","volume":"8","author":"Carro","year":"2002","journal-title":"Nat Med"},{"key":"10.1016\/j.neurobiolaging.2005.09.039_bib11","unstructured":"Carro E, Spuch C, Trejo JL, Antequera D, Torres-Aleman I, Choroid plexas megalin is involved in neuroprotection by serum insulin-like growth factor I. J. Neurosci [in press]."},{"issue":"6","key":"10.1016\/j.neurobiolaging.2005.09.039_bib12","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0168-9525(02)02696-3","article-title":"A critical analysis of the role of growth hormone and IGF-1 in aging and lifespan","volume":"18","author":"Carter","year":"2002","journal-title":"Trends Genet"},{"issue":"1","key":"10.1016\/j.neurobiolaging.2005.09.039_bib13","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/nn1372","article-title":"Natural oligomers of the amyloid-[beta] protein specifically disrupt cognitive function","volume":"8","author":"Cleary","year":"2005","journal-title":"Nat Neurosci"},{"issue":"1","key":"10.1016\/j.neurobiolaging.2005.09.039_bib14","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0165-0173(01)00067-4","article-title":"Applications of the Morris water maze in the study of learning and memory","volume":"36","author":"D\u2019Hooge","year":"2001","journal-title":"Brain Res Brain Res Rev"},{"issue":"3","key":"10.1016\/j.neurobiolaging.2005.09.039_bib15","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0166-2236(95)93892-2","article-title":"The developing CNS: a scenario for the action of proinsulin, insulin and insulin-like growth factors","volume":"18","author":"de Pablo","year":"1995","journal-title":"Trends Neurosci"},{"issue":"20","key":"10.1016\/j.neurobiolaging.2005.09.039_bib16","doi-asserted-by":"crossref","first-page":"4932","DOI":"10.1002\/j.1460-2075.1995.tb00176.x","article-title":"Production of intracellular amyloid-containing fragments in hippocampal neurons expressing human amyloid precursor protein and protection against amyloidogenesis by subtle amino acid substitutions in the rodent sequence","volume":"14","author":"De Strooper","year":"1995","journal-title":"EMBO J"},{"issue":"15","key":"10.1016\/j.neurobiolaging.2005.09.039_bib17","doi-asserted-by":"crossref","first-page":"8850","DOI":"10.1073\/pnas.151261398","article-title":"Peripheral anti-A beta antibody alters CNS and plasma A beta clearance and decreases brain A beta burden in a mouse model of Alzheimer's disease","volume":"98","author":"DeMattos","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"10.1016\/j.neurobiolaging.2005.09.039_bib18","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1006\/mthe.2001.0431","article-title":"Production and neurotropism of lentivirus vectors pseudotyped with lyssavirus envelope glycoproteins","volume":"4","author":"Desmaris","year":"2001","journal-title":"Mol Ther"},{"issue":"15","key":"10.1016\/j.neurobiolaging.2005.09.039_bib19","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1101\/gad.908001","article-title":"Functional inactivation of the IGF-I and insulin receptors in skeletal muscle causes type 2 diabetes","volume":"15","author":"Fernandez","year":"2001","journal-title":"Genes Dev"},{"issue":"6","key":"10.1016\/j.neurobiolaging.2005.09.039_bib20","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/S0165-6147(02)02037-0","article-title":"Does insulin dysfunction play a role in Alzheimer's disease?","volume":"23","author":"Gasparini","year":"2002","journal-title":"Trends Pharmacol Sci"},{"issue":"8","key":"10.1016\/j.neurobiolaging.2005.09.039_bib21","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/S0166-2236(03)00163-2","article-title":"Potential roles of insulin and IGF-1 in Alzheimer's disease","volume":"26","author":"Gasparini","year":"2003","journal-title":"Trends Neurosci"},{"issue":"1","key":"10.1016\/j.neurobiolaging.2005.09.039_bib22","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1172\/JCI200317527","article-title":"Alzheimer disease therapy: can the amyloid cascade be halted?","volume":"111","author":"Golde","year":"2003","journal-title":"J Clin Invest"},{"issue":"13","key":"10.1016\/j.neurobiolaging.2005.09.039_bib23","doi-asserted-by":"crossref","first-page":"7013","DOI":"10.1074\/jbc.270.13.7013","article-title":"Amyloid beta protein (A beta) in Alzheimer's disease brain. Biochemical and immunocytochemical analysis with antibodies specific for forms ending at A beta 40 or A beta 42(43)","volume":"270","author":"Gravina","year":"1995","journal-title":"J Biol Chem"},{"issue":"30","key":"10.1016\/j.neurobiolaging.2005.09.039_bib24","doi-asserted-by":"crossref","first-page":"18644","DOI":"10.1074\/jbc.272.30.18644","article-title":"Interaction of apolipoprotein J-amyloid beta-peptide complex with low density lipoprotein receptor-related protein-2\/megalin. A mechanism to prevent pathological accumulation of amyloid beta-peptide","volume":"272","author":"Hammad","year":"1997","journal-title":"J Biol Chem"},{"issue":"10","key":"10.1016\/j.neurobiolaging.2005.09.039_bib25","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1016\/S0168-9525(01)02449-0","article-title":"Transgenic mouse models of Alzheimer's disease","volume":"17","author":"Hock","year":"2001","journal-title":"Trends Genet"},{"issue":"3","key":"10.1016\/j.neurobiolaging.2005.09.039_bib26","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1023\/A:1021691918517","article-title":"Behavioral changes in transgenic mice expressing both amyloid precursor protein and presenilin-1 mutations: lack of association with amyloid deposits","volume":"29","author":"Holcomb","year":"1999","journal-title":"Behav Genet"},{"issue":"11","key":"10.1016\/j.neurobiolaging.2005.09.039_bib27","doi-asserted-by":"crossref","first-page":"6370","DOI":"10.1073\/pnas.1237107100","article-title":"Spherical aggregates of beta-amyloid (amylospheroid) show high neurotoxicity and activate tau protein kinase I\/glycogen synthase kinase-3beta","volume":"100","author":"Hoshi","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"10.1016\/j.neurobiolaging.2005.09.039_bib28","first-page":"113","article-title":"Morphology and distribution of plaque and related deposits in the brains of Alzheimer's disease and control cases. An immunohistochemical study using amyloid beta-protein antibody","volume":"60","author":"Ikeda","year":"1989","journal-title":"Lab Invest"},{"issue":"6","key":"10.1016\/j.neurobiolaging.2005.09.039_bib29","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1212\/01.WNL.0000115115.98960.37","article-title":"Early Abeta accumulation and progressive synaptic loss, gliosis, and tangle formation in AD brain","volume":"62","author":"Ingelsson","year":"2004","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.neurobiolaging.2005.09.039_bib30","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1210\/er.19.5.625","article-title":"Insulin-like growth factor-I resistance","volume":"19","author":"Jain","year":"1998","journal-title":"Endocr Rev"},{"issue":"4","key":"10.1016\/j.neurobiolaging.2005.09.039_bib31","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1016\/S0021-9258(18)53824-2","article-title":"Role of tyrosine kinase activity in signal transduction by the insulin-like growth factor-I (IGF-I) receptor. Characterization of kinase-deficient IGF-I receptors and the action of an IGF-I-mimetic antibody (alpha IR-3)","volume":"268","author":"Kato","year":"1993","journal-title":"J Biol Chem"},{"issue":"2","key":"10.1016\/j.neurobiolaging.2005.09.039_bib32","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1523\/JNEUROSCI.21-02-00372.2001","article-title":"Age-dependent changes in brain, CSF, and plasma amyloid (beta) protein in the Tg2576 transgenic mouse model of Alzheimer's disease","volume":"21","author":"Kawarabayashi","year":"2001","journal-title":"J Neurosci"},{"issue":"36","key":"10.1016\/j.neurobiolaging.2005.09.039_bib33","doi-asserted-by":"crossref","first-page":"31746","DOI":"10.1074\/jbc.M503259200","article-title":"Beta-amyloid-induced dynamin 1 depletion in hippocammpal neurons: a potential mechanism for early cognitive decline in Alzheimer's disease","volume":"280","author":"Kelly","year":"2005","journal-title":"J Biol Chem"},{"issue":"7","key":"10.1016\/j.neurobiolaging.2005.09.039_bib34","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/S0166-2236(03)00164-4","article-title":"Modeling CNS neurodegeneration by overexpression of disease-causing proteins using viral vectors","volume":"26","author":"Kirik","year":"2003","journal-title":"Trends Neurosci"},{"issue":"1","key":"10.1016\/j.neurobiolaging.2005.09.039_bib35","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1006\/nbdi.1999.0272","article-title":"Behavioral disturbances without amyloid deposits in mice overexpressing human amyloid precursor protein with Flemish (A692G) or Dutch (E693Q) mutation","volume":"7","author":"Kumar-Singh","year":"2000","journal-title":"Neurobiol Dis"},{"issue":"6","key":"10.1016\/j.neurobiolaging.2005.09.039_bib36","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/S0197-4580(02)00228-2","article-title":"Comparative distribution of tau phosphorylated at Ser262 in pre-tangles and tangles","volume":"24","author":"Lauckner","year":"2003","journal-title":"Neurobiol Aging"},{"issue":"4","key":"10.1016\/j.neurobiolaging.2005.09.039_bib37","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0197-4580(03)00127-1","article-title":"Chlamydia pneumoniae induces Alzheimer-like amyloid plaques in brains of BALB\/c mice","volume":"25","author":"Little","year":"2004","journal-title":"Neurobiol Aging"},{"issue":"6","key":"10.1016\/j.neurobiolaging.2005.09.039_bib38","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1046\/j.1471-4159.2003.02070.x","article-title":"Overactivation of glycogen synthase kinase-3 by inhibition of phosphoinositol-3 kinase and protein kinase C leads to hyperphosphorylation of tau and impairment of spatial memory","volume":"87","author":"Liu","year":"2003","journal-title":"J Neurochem"},{"issue":"4","key":"10.1016\/j.neurobiolaging.2005.09.039_bib39","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/jnr.10791","article-title":"Systemic insulin-like growth factor-I administration prevents cognitive impairment in diabetic rats, and brain IGF regulates learning\/memory in normal adult rats","volume":"74","author":"Lupien","year":"2003","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.neurobiolaging.2005.09.039_bib40","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1146\/annurev.neuro.26.043002.094919","article-title":"Epidemiology of neurodegeneration","volume":"26","author":"Mayeux","year":"2003","journal-title":"Annu Rev Neurosci"},{"issue":"12","key":"10.1016\/j.neurobiolaging.2005.09.039_bib41","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1097\/00005072-199812000-00012","article-title":"Curly fiber and tangle-like inclusions in the ependyma and choroid plexus\u2014a pathogenetic relationship with the cortical Alzheimer-type changes?","volume":"57","author":"Miklossy","year":"1998","journal-title":"J Neuropathol Exp Neurol"},{"issue":"1","key":"10.1016\/j.neurobiolaging.2005.09.039_bib42","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0165-0270(84)90007-4","article-title":"Developments of a water-maze procedure for studying spatial learning in the rat","volume":"11","author":"Morris","year":"1984","journal-title":"J Neurosci Methods"},{"issue":"22","key":"10.1016\/j.neurobiolaging.2005.09.039_bib43","doi-asserted-by":"crossref","first-page":"13238","DOI":"10.1016\/S0021-9258(18)51620-3","article-title":"Insulin-like growth factor I receptor beta-subunit heterogeneity. Evidence for hybrid tetramers composed of insulin-like growth factor I and insulin receptor heterodimers","volume":"264","author":"Moxham","year":"1989","journal-title":"J Biol Chem"},{"issue":"3","key":"10.1016\/j.neurobiolaging.2005.09.039_bib44","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0896-6273(03)00434-3","article-title":"Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction","volume":"39","author":"Oddo","year":"2003","journal-title":"Neuron"},{"issue":"10","key":"10.1016\/j.neurobiolaging.2005.09.039_bib45","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1523\/JNEUROSCI.5561-03.2004","article-title":"Alterations in glucose metabolism induce hypothermia leading to tau hyperphosphorylation through differential inhibition of kinase and phosphatase activities: implications for Alzheimer's disease","volume":"24","author":"Planel","year":"2004","journal-title":"J Neurosci"},{"issue":"49","key":"10.1016\/j.neurobiolaging.2005.09.039_bib46","doi-asserted-by":"crossref","first-page":"38620","DOI":"10.1074\/jbc.M004531200","article-title":"Insulin-like growth factor-I stimulates dephosphorylation of Ikappa b through the serine phosphatase calcineurin (protein phosphatase 2B)","volume":"275","author":"Pons","year":"2000","journal-title":"J Biol Chem"},{"issue":"3","key":"10.1016\/j.neurobiolaging.2005.09.039_bib47","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/S0969-9961(02)00012-8","article-title":"Normal cognitive behavior in two distinct congenic lines of transgenic mice hyperexpressing mutant APP SWE","volume":"12","author":"Savonenko","year":"2003","journal-title":"Neurobiol Dis"},{"issue":"9","key":"10.1016\/j.neurobiolaging.2005.09.039_bib48","doi-asserted-by":"crossref","first-page":"3100","DOI":"10.1073\/pnas.0308724101","article-title":"Role for neuronal insulin resistance in neurodegenerative diseases","volume":"101","author":"Schubert","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"10.1016\/j.neurobiolaging.2005.09.039_bib49","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.expneurol.2004.03.016","article-title":"Transgenic mice overexpressing amyloid beta protein are an incomplete model of Alzheimer disease","volume":"188","author":"Schwab","year":"2004","journal-title":"Exp Neurol"},{"issue":"2","key":"10.1016\/j.neurobiolaging.2005.09.039_bib50","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0896-6273(01)00475-5","article-title":"Clearing the brain's amyloid cobwebs","volume":"32","author":"Selkoe","year":"2001","journal-title":"Neuron"},{"key":"10.1016\/j.neurobiolaging.2005.09.039_bib51","doi-asserted-by":"crossref","first-page":"S515","DOI":"10.2741\/1085","article-title":"Choroid plexus, ageing of the brain, and Alzheimer's disease","volume":"8","author":"Serot","year":"2003","journal-title":"Front Biosci"},{"issue":"17","key":"10.1016\/j.neurobiolaging.2005.09.039_bib52","doi-asserted-by":"crossref","first-page":"7380","DOI":"10.1523\/JNEUROSCI.22-17-07380.2002","article-title":"Lack of neurodegeneration in transgenic mice overexpressing mutant amyloid precursor protein is associated with increased levels of transthyretin and the activation of cell survival pathways","volume":"22","author":"Stein","year":"2002","journal-title":"J Neurosci"},{"issue":"5163","key":"10.1016\/j.neurobiolaging.2005.09.039_bib53","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1126\/science.8191290","article-title":"An increased percentage of long amyloid beta protein secreted by familial amyloid beta protein precursor (beta APP717) mutants","volume":"264","author":"Suzuki","year":"1994","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.neurobiolaging.2005.09.039_bib54","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/BF02257671","article-title":"Insulin-like growth factors and insulin-like growth factor binding proteins in cerebrospinal fluid and serum of patients with dementia of the Alzheimer type","volume":"5","author":"Tham","year":"1993","journal-title":"J Neural Transm Park Dis Dement Sect"},{"issue":"4","key":"10.1016\/j.neurobiolaging.2005.09.039_bib55","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0891-0618(01)00120-X","article-title":"Amyloid beta peptide levels and its effects on hippocampal acetylcholine release in aged, cognitively-impaired and -unimpaired rats","volume":"21","author":"Vaucher","year":"2001","journal-title":"J Chem Neuroanat"},{"issue":"10","key":"10.1016\/j.neurobiolaging.2005.09.039_bib56","doi-asserted-by":"crossref","first-page":"RC221","DOI":"10.1523\/JNEUROSCI.22-10-j0001.2002","article-title":"Alzheimer's beta-amyloid peptides compete for insulin binding to the insulin receptor","volume":"22","author":"Xie","year":"2002","journal-title":"J Neurosci"},{"issue":"13","key":"10.1016\/j.neurobiolaging.2005.09.039_bib57","doi-asserted-by":"crossref","first-page":"7324","DOI":"10.1073\/pnas.96.13.7324","article-title":"Normal growth and development in the absence of hepatic insulin-like growth factor I","volume":"96","author":"Yakar","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"10.1016\/j.neurobiolaging.2005.09.039_bib58","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0969-9961(02)00009-8","article-title":"Defects in expression of genes related to synaptic vesicle trafficking in frontal cortex of Alzheimer's disease","volume":"12","author":"Yao","year":"2003","journal-title":"Neurobiol Dis"},{"issue":"1","key":"10.1016\/j.neurobiolaging.2005.09.039_bib59","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/83292","article-title":"Amyloid beta vaccination: reduced plaques and improved cognition","volume":"7","author":"Younkin","year":"2001","journal-title":"Nat Med"},{"issue":"9","key":"10.1016\/j.neurobiolaging.2005.09.039_bib60","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1038\/nbt0997-871","article-title":"Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo","volume":"15","author":"Zufferey","year":"1997","journal-title":"Nat Biotechnol"}],"container-title":["Neurobiology of Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S019745800500309X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S019745800500309X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,7,19]],"date-time":"2021-07-19T09:52:35Z","timestamp":1626688355000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S019745800500309X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,11]]},"references-count":60,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2006,11]]}},"alternative-id":["S019745800500309X"],"URL":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2005.09.039","relation":{},"ISSN":["0197-4580"],"issn-type":[{"value":"0197-4580","type":"print"}],"subject":[],"published":{"date-parts":[[2006,11]]}}}